Anhui Zhifei Longcoma’s New Crown vaccine is effective. Anhui Zhifei’s Lungkoma vaccine is one of the main Lungkoma vaccines used in China, and has been proven in a large number of clinical vaccinations to be effective in forming antibodies in the body of the vaccinated person, thus achieving a more comprehensive protection for the vaccinated person. All vaccines have adverse reactions, mainly related to the inoculant’s history of allergy, tolerance level and other factors, including local redness, swelling, hardness, muscle pain, fatigue, etc., but the general degree is relatively mild, belongs to the normal range, and generally can be self-healing, such as the emergence of more serious adverse reactions need to consult a doctor in a timely manner, in order to avoid leading to anaphylactic shock and other situations. It is recommended that the individual’s physical condition permits, active vaccination, to maintain their own health.